DWTX Stock Analysis: Buy, Sell, or Hold?
DWTX - Dogwood Therapeutics, Inc. Common Stock
$2.11
0.33 (18.54%)
▲
5d:
-18.53%
30d:
-25.18%
90d:
-49.76%
WAIT
LOW Confidence
Analysis Updated: Mar 31, 2026 12:00 AM ET
Earnings: May 14, 2026
Get Alerted When DWTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: DWTX is down 18.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: DWTX is down 18.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: DWTX is currently trading at $2.11, which is considered oversold relative to its 30-day fair value range of $2.38 to $3.12.
Technical Outlook: Technically, DWTX is in a strong downtrend. Immediate support is located at $1.77, while resistance sits at $3.37. The stock is showing strong short-term momentum, up 18.5% recently.
Market Sentiment: DWTX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $14.00 (+563.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DWTX is in a strong downtrend. Immediate support is located at $1.77, while resistance sits at $3.37. The stock is showing strong short-term momentum, up 18.5% recently.
Market Sentiment: DWTX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $14.00 (+563.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$2.38 -
$3.12
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+18.5%)
- BULLISH: Trading 563.5% below Wall St target ($14.00)
- WARNING: Recommendation downgraded due to -18.5% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$2.38 -
$3.12
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.77
Resistance Level
$3.37
Current Trend
Strong Downtrend
Technical data as of
Mar 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.17
Wall Street Target
$14.00
(+563.5%)
Share & Embed Analysis
Last updated: April 01, 2026 6:07 AM ET
Data refreshes hourly during market hours. Next update: 7:07 AM
Data refreshes hourly during market hours. Next update: 7:07 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DWTX showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$89 | 60 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 58 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1018 | 61 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 54 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 47 HOLD |
